Normal view MARC view ISBD view

[T- and B-lymphocytes in the so-called collagenoses]. [electronic resource]

By:

Standhofer, M

Contributor(s):

Producer: 19760402Description: 418-24 p. digitalISSN:

0340-1855

Subject(s):

In: Zeitschrift fur Rheumatologie vol. 34

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: English Abstract; Journal Article

There are no comments on this title.

to post a comment.

Back to results

6641 Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
by Ceci, Claudia
6642 Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.
by Kiyohara, Yoshio
6643 Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
by Rebelatto, Marlon C
6644 Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
by Li, Chia-Wei
6645 Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
by Gray, Michael J
6646 Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
by Chowdhury, Subrata
6647 The role of TNF-α in chordoma progression and inflammatory pathways.
by Gulluoglu, Sukru
6648 IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer.
by Ritzmann, Felix
6649 High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination.
by Arlt, Annekatrin
6650 Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.
by Li, Shuang
6651 Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer.
by Feng, Bohai
6652 Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
by Zuo, Hong Xiang
6653 Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment.
by Onuma, Amblessed E
6654 A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
by Ju, Songwen
6655 Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance.
by Fukaya, Tomohiro
6656 Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
by Hatam, Lynda J
6657 MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.
by Steidl, Christian
6658 Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy.
by Koido, Shigeo
6659 Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.
by Shalapour, Shabnam
6660 Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.
by Xu, Chunxiao